Radiotherapy and hyperthermia in the treatment of fibrosarcomas in the dog.
Ten dogs with oral or external nasal fibrosarcoma were treated sequentially with orthovoltage radiation and radiofrequency (RF)-induced hyperthermia. Total radiation doses ranged from 3,200 to 4,800 rad given in 8 to 12 fractions of 400 rad. Immediately after 2 to 4 radiation treatments, hyperthermia was given. Six oral fibrosarcomas were heated to 50 C for 30 sec, using a hand-held RF generator. Four nasomaxillary fibrosarcomas were heated to 43 C for 30 minutes, using a 500-kHz RF generator. Hyperthermia of 50 C resulted in tumor necrosis and infection in 3 dogs and fatal septicemia in 1 dog. Nine of 10 tumors responded to therapy. One year after therapy, 5 dogs were free of disease. Tumor regrowth occurred in 5 dogs. Mean time to tumor regrowth and mean survival time of all dogs were 343 and 398 days, respectively. The results suggested that sequential radiation-hyperthermia is an effective therapeutic regimen for canine fibrosarcoma. It was concluded that this modality not only may be beneficial in the treatment of canine tumors but may be useful for designing new therapeutic approaches to similar tumors in man.
D000818:Animals; D004283:Dog Diseases / Q000532:radiotherapy / Q000628:therapy*; D004285:Dogs; D005260:Female; D005354:Fibrosarcoma / Q000532:radiotherapy / Q000628:therapy / Q000662:veterinary*; D005887:Gingival Neoplasms / Q000532:radiotherapy / Q000628:therapy / Q000662:veterinary; D006979:Hyperthermia, Induced / Q000662:veterinary*; D008297:Male; D008441:Maxillary Neoplasms / Q000532:radiotherapy / Q000628:therapy / Q000662:veterinary*; D009062:Mouth Neoplasms / Q000662:veterinary*; D009669:Nose Neoplasms / Q000532:radiotherapy / Q000628:therapy / Q000662:veterinary*; D010157:Palatal Neoplasms / Q000532:radiotherapy / Q000628:therapy / Q000662:veterinary; D011379:Prognosis